Is isoniazid safe for liver transplant candidates with latent tuberculosis?

Transplantation proceedings

Volumn 44, Issue 8, 2012, Pages 2406-2410

  Stucchi, R S ^a   Boin, I F ^b   Angerami, R N ^b   Zanaga, L ^b   Ataide, E C ^b   Udo, E Y ^b  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; BIOLOGICAL MARKER; ISONIAZID; TUBERCULOSTATIC AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD; BRAZIL; CHEMICALLY INDUCED DISORDER; DRUG ADMINISTRATION; END STAGE LIVER DISEASE; FEMALE; HUMAN; LATENT TUBERCULOSIS; LIVER TRANSPLANTATION; MALE; MICROBIOLOGY; MIDDLE AGED; POSTOPERATIVE COMPLICATION; RETROSPECTIVE STUDY; TIME; TREATMENT OUTCOME; TUBERCULIN TEST;

ADOLESCENT; ADULT; AGED; ALANINE TRANSAMINASE; ANTITUBERCULAR AGENTS; BIOLOGICAL MARKERS; BRAZIL; DRUG ADMINISTRATION SCHEDULE; END STAGE LIVER DISEASE; FEMALE; HUMANS; ISONIAZID; LATENT TUBERCULOSIS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; TUBERCULIN TEST;

MLCS; MLOWN;

EID: 84874803034     PISSN: None     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2012.07.035     Document Type: Article

References (0)